- Home
- AIFU vs XGN Comparison
AIFU vs XGN Comparison
Compare AIFU & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIFU
- XGN
- Stock Information
- Founded
- AIFU 1998
- XGN 2002
- Country
- AIFU China
- XGN United States
- Employees
- AIFU N/A
- XGN N/A
- Industry
- AIFU
- XGN Medical Specialities
- Sector
- AIFU
- XGN Health Care
- Exchange
- AIFU NYSE
- XGN Nasdaq
- Market Cap
- AIFU 61.0M
- XGN 72.3M
- IPO Year
- AIFU 2007
- XGN 2019
- Fundamental
- Price
- AIFU $0.43
- XGN $4.00
- Analyst Decision
- AIFU
- XGN Strong Buy
- Analyst Count
- AIFU 0
- XGN 2
- Target Price
- AIFU N/A
- XGN $7.50
- AVG Volume (30 Days)
- AIFU 1.5M
- XGN 206.7K
- Earning Date
- AIFU 03-18-2025
- XGN 03-17-2025
- Dividend Yield
- AIFU N/A
- XGN N/A
- EPS Growth
- AIFU N/A
- XGN N/A
- EPS
- AIFU 0.38
- XGN N/A
- Revenue
- AIFU $324,923,970.00
- XGN $55,751,000.00
- Revenue This Year
- AIFU N/A
- XGN $6.81
- Revenue Next Year
- AIFU $11.81
- XGN $17.72
- P/E Ratio
- AIFU $1.14
- XGN N/A
- Revenue Growth
- AIFU N/A
- XGN 8.00
- 52 Week Low
- AIFU $0.33
- XGN $1.30
- 52 Week High
- AIFU $6.59
- XGN $6.22
- Technical
- Relative Strength Index (RSI)
- AIFU N/A
- XGN 51.98
- Support Level
- AIFU N/A
- XGN $3.83
- Resistance Level
- AIFU N/A
- XGN $4.22
- Average True Range (ATR)
- AIFU 0.00
- XGN 0.41
- MACD
- AIFU 0.00
- XGN 0.07
- Stochastic Oscillator
- AIFU 0.00
- XGN 84.93
About AIFU FANHUA INC SPON ADS EACH REPR 20 ORD SHS
AIX Inc is a technology-driven financial services provider company in China. It is an intelligent platform that creates a supportive and collaborative environment and provides solutions that integrate technology, products, services, operations, capital, and professional support for individual agents and sales organizations. The group uses technology, AI, and data-driven insights, pioneering the financial services that are delivered, its transformation, and empowering industry development. It connects customers with financial institutions, investment opportunities, and service providers, offering insurance, wealth management, and other value-added services.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.